ArticleJMIR research protocols2025
A Dashboard for Managing an Ecosystem and People With Dementia: Protocol for a Healthy Ageing Ecosystem for People With Dementia (HAAL) International Feasibility Pilot Study.
Article in JMIR research protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Authors' Reply: Posttrial Withdrawal Ethics in the Healthy Ageing Ecosystem for People With Dementia (HAAL) Study.JMIR research protocols · 2026Article
- Posttrial Withdrawal Ethics in the Healthy Ageing Ecosystem for People With Dementia (HAAL) Study.JMIR research protocols · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDementia is a syndrome characterized by a wide spectrum of symptoms and needs. There is no cure for this syndrome, which represents a major challenge to society in terms of quality of life for those affected and in terms of workload and stress burden for those who take care of them.
objectiveThe Healthy Ageing Ecosystem for People With Dementia (HAAL) aimed to improve the quality of life of both people with dementia and their formal caregivers (FCs) and informal caregivers (ICs) by providing a personalized set of devices to the person with dementia, along with a dashboard designed for caregivers to monitor and manage the older person.
methodsThe HAAL platform comprises a dashboard that integrates, aggregates, and analyzes heterogeneous data gathered from an ecosystem of devices designed for and tested with people with dementia. The study was designed as a technical feasibility pilot to test the HAAL ecosystem in 3 countries: Italy, Taiwan, and the Netherlands, where older people with initial, moderate, and severe dementia were enrolled, respectively. The study was run in 2 stages: the alpha and beta pilot studies aimed to test the second and third prototypes of the platform, respectively.
resultsThe alpha test was conducted from March to May 2023, involving 41 end users, of which 13 were people with dementia, 13 were ICs, and 15 were FCs. The beta test was conducted from September 2023 to February 2024, involving 83 end users, of which 26 were people with dementia, 20 were ICs, and 37 were FCs. The results have been elaborated and are supposed to be published by 2026.
conclusionsThe HAAL pilot study was an innovative feasibility study whose primary objectives were to assess reduction in care load for FCs, stress relief for FCs and ICs, and improvement in the perceived quality of life for ICs and people with dementia. The study also evaluated the usability and the acceptance of the platform. Preliminary analyses of the results showed that the HAAL platform partially relieved caregivers' stress and that the quality of life of people with dementia did not worsen over the test period. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR1-10.2196/59860.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.